A. Kastrati

1.6k total citations
14 papers, 1.2k citations indexed

About

A. Kastrati is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, A. Kastrati has authored 14 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 6 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in A. Kastrati's work include Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Coronary Interventions and Diagnostics (5 papers) and Acute Myocardial Infarction Research (4 papers). A. Kastrati is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Coronary Interventions and Diagnostics (5 papers) and Acute Myocardial Infarction Research (4 papers). A. Kastrati collaborates with scholars based in Germany, United States and Switzerland. A. Kastrati's co-authors include Albert Schömig, Robert A. Byrne, Steffen Maßberg, Dirk Taubert, A. Lazar, Gundula Grimberg, Namhee Jung, Julinda Mehilli, Edgar Schömig and Tobias Goeser and has published in prestigious journals such as Journal of the American Society of Nephrology, European Heart Journal and Human Molecular Genetics.

In The Last Decade

A. Kastrati

14 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Kastrati Germany 12 873 663 188 154 140 14 1.2k
Axel Åkerblom Sweden 17 745 0.9× 323 0.5× 143 0.8× 118 0.8× 60 0.4× 42 1.1k
Joseph Sweeny United States 18 888 1.0× 845 1.3× 103 0.5× 467 3.0× 216 1.5× 95 1.6k
Ronan J. Curtin United States 15 998 1.1× 331 0.5× 70 0.4× 380 2.5× 157 1.1× 33 1.3k
Seok-Jae Hwang South Korea 12 1.4k 1.6× 281 0.4× 128 0.7× 222 1.4× 343 2.5× 19 1.6k
Ji‐Lin Chen China 16 479 0.5× 489 0.7× 62 0.3× 235 1.5× 178 1.3× 96 883
Tae Hoon Ahn South Korea 18 702 0.8× 502 0.8× 296 1.6× 134 0.9× 114 0.8× 90 1.2k
Erik W. Holy Switzerland 21 809 0.9× 200 0.3× 67 0.4× 134 0.9× 238 1.7× 46 1.4k
Lucie Lacoste Canada 11 524 0.6× 449 0.7× 97 0.5× 111 0.7× 75 0.5× 13 981
Zubair Shah United States 18 571 0.7× 397 0.6× 124 0.7× 67 0.4× 81 0.6× 84 1.2k
Noriaki Tabata Japan 17 536 0.6× 235 0.4× 91 0.5× 209 1.4× 81 0.6× 78 861

Countries citing papers authored by A. Kastrati

Since Specialization
Citations

This map shows the geographic impact of A. Kastrati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Kastrati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Kastrati more than expected).

Fields of papers citing papers by A. Kastrati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Kastrati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Kastrati. The network helps show where A. Kastrati may publish in the future.

Co-authorship network of co-authors of A. Kastrati

This figure shows the co-authorship network connecting the top 25 collaborators of A. Kastrati. A scholar is included among the top collaborators of A. Kastrati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Kastrati. A. Kastrati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Hadamitzky, Martin, Bettina Langhans, Jöerg Hausleiter, et al.. (2013). Prognostic value of late gadolinium enhancement in cardiovascular magnetic resonance imaging after acute ST-elevation myocardial infarction in comparison with single-photon emission tomography using Tc99m-Sestamibi. European Heart Journal - Cardiovascular Imaging. 15(2). 216–225. 37 indexed citations
3.
Sibbing, Dirk, Steffen Maßberg, Robert A. Byrne, et al.. (2011). No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stenting. European Heart Journal. 32(13). 1605–1613. 144 indexed citations
4.
Schulz, S., Julinda Mehilli, Gjin Ndrepepa, et al.. (2010). Bivalirudin vs. unfractionated heparin during percutaneous coronary interventions in patients with stable and unstable angina pectoris: 1-year results of the ISAR-REACT 3 trial. European Heart Journal. 31(5). 582–587. 47 indexed citations
5.
Sibbing, Dirk, G Busch, S Braun, et al.. (2008). Impact of bivalirudin or unfractionated heparin on platelet aggregation in patients pretreated with 600 mg clopidogrel undergoing elective percutaneous coronary intervention. European Heart Journal. 29(12). 1504–1509. 35 indexed citations
6.
Hoppmann, Petra, et al.. (2008). Polymorphisms in thrombospondin genes and myocardial infarction: a case-control study and a meta-analysis of available evidence. Human Molecular Genetics. 17(8). 1120–1126. 28 indexed citations
7.
Iijima, Raisuke, Gjin Ndrepepa, Julinda Mehilli, et al.. (2008). Profile of bleeding and ischaemic complications with bivalirudin and unfractionated heparin after percutaneous coronary intervention. European Heart Journal. 30(3). 290–296. 44 indexed citations
8.
Adriaenssens, Tom, Robert A. Byrne, Alban Dibra, et al.. (2008). Culotte stenting technique in coronary bifurcation disease: angiographic follow-up using dedicated quantitative coronary angiographic analysis and 12-month clinical outcomes. European Heart Journal. 29(23). 2868–2876. 79 indexed citations
9.
Byrne, Robert A. & A. Kastrati. (2008). Duration of antiplatelet therapy following intracoronary stenting: are changes needed?. European Heart Journal Supplements. 10(Suppl I). I25–I29. 6 indexed citations
10.
Tiroch, Klaus, et al.. (2007). Heme oxygenase-1 gene promoter polymorphism and restenosis following coronary stenting. European Heart Journal. 28(8). 968–973. 36 indexed citations
11.
Koch, Werner, Petra Hoppmann, Arne Pfeufer, Albert Schömig, & A. Kastrati. (2006). Toll-like receptor 4 gene polymorphisms and myocardial infarction: no association in a Caucasian population. European Heart Journal. 27(21). 2524–2529. 53 indexed citations
12.
Schwaiger, Markus, et al.. (2006). Stem Cell Therapy after Acute Myocardial Infarction—The Emperor’s New Clothes?. Journal of the American Society of Nephrology. 17(5). 1207–1217. 9 indexed citations
13.
Taubert, Dirk, Gundula Grimberg, A. Lazar, et al.. (2006). Impact of P-glycoprotein on clopidogrel absorption. Clinical Pharmacology & Therapeutics. 80(5). 486–501. 330 indexed citations
14.
Milz, Stefan, Michael Vogeser, Thomas Mund, et al.. (2005). Local statin therapy differentially interferes with smooth muscle and endothelial cell proliferation and reduces neointima on a drug-eluting stent platform. Cardiovascular Research. 68(3). 483–492. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026